293 related articles for article (PubMed ID: 18413721)
1. Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation.
Rodriguez-Gonzalez A; Lin T; Ikeda AK; Simms-Waldrip T; Fu C; Sakamoto KM
Cancer Res; 2008 Apr; 68(8):2557-60. PubMed ID: 18413721
[TBL] [Abstract][Full Text] [Related]
2. Autophagy: links with the proteasome.
Lamark T; Johansen T
Curr Opin Cell Biol; 2010 Apr; 22(2):192-8. PubMed ID: 19962293
[TBL] [Abstract][Full Text] [Related]
3. [A new mechanism of ubiquitin-dependent proteolytic pathway--polyubiquitin chain recognition and proteasomal targeting].
Kawahara H; Yokosawa H
Gan To Kagaku Ryoho; 2008 Jan; 35(1):11-5. PubMed ID: 18195523
[TBL] [Abstract][Full Text] [Related]
4. A role for ubiquitin in selective autophagy.
Kirkin V; McEwan DG; Novak I; Dikic I
Mol Cell; 2009 May; 34(3):259-69. PubMed ID: 19450525
[TBL] [Abstract][Full Text] [Related]
5. Aggresome formation.
Corboy MJ; Thomas PJ; Wigley WC
Methods Mol Biol; 2005; 301():305-27. PubMed ID: 15917642
[TBL] [Abstract][Full Text] [Related]
6. BAG3 and friends: co-chaperones in selective autophagy during aging and disease.
Behl C
Autophagy; 2011 Jul; 7(7):795-8. PubMed ID: 21681022
[TBL] [Abstract][Full Text] [Related]
7. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
[TBL] [Abstract][Full Text] [Related]
8. Proteasomes activate aggresome disassembly and clearance by producing unanchored ubiquitin chains.
Hao R; Nanduri P; Rao Y; Panichelli RS; Ito A; Yoshida M; Yao TP
Mol Cell; 2013 Sep; 51(6):819-28. PubMed ID: 24035499
[TBL] [Abstract][Full Text] [Related]
9. Neuronal DnaJ proteins HSJ1a and HSJ1b: a role in linking the Hsp70 chaperone machine to the ubiquitin-proteasome system?
Chapple JP; van der Spuy J; Poopalasundaram S; Cheetham ME
Biochem Soc Trans; 2004 Aug; 32(Pt 4):640-2. PubMed ID: 15270696
[TBL] [Abstract][Full Text] [Related]
10. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
[TBL] [Abstract][Full Text] [Related]
11. The regulation of proteasome degradation by multi-ubiquitin chain binding proteins.
Miller J; Gordon C
FEBS Lett; 2005 Jun; 579(15):3224-30. PubMed ID: 15943965
[TBL] [Abstract][Full Text] [Related]
12. Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.
Vandenberghe I; Créancier L; Vispé S; Annereau JP; Barret JM; Pouny I; Samson A; Aussagues Y; Massiot G; Ausseil F; Bailly C; Kruczynski A
Biochem Pharmacol; 2008 Aug; 76(4):453-62. PubMed ID: 18577376
[TBL] [Abstract][Full Text] [Related]
13. Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways.
Liu H; Wang P; Song W; Sun X
FASEB J; 2009 Oct; 23(10):3383-92. PubMed ID: 19509306
[TBL] [Abstract][Full Text] [Related]
14. Clearance of misfolded and aggregated proteins by aggrephagy and implications for aggregation diseases.
Hyttinen JM; Amadio M; Viiri J; Pascale A; Salminen A; Kaarniranta K
Ageing Res Rev; 2014 Nov; 18():16-28. PubMed ID: 25062811
[TBL] [Abstract][Full Text] [Related]
15. Chaperone-mediated 26S proteasome remodeling facilitates free K63 ubiquitin chain production and aggresome clearance.
Nanduri P; Hao R; Fitzpatrick T; Yao TP
J Biol Chem; 2015 Apr; 290(15):9455-64. PubMed ID: 25713068
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin-A-induced prion protein aggresomes are dynamic quality-control cellular compartments.
Ben-Gedalya T; Lyakhovetsky R; Yedidia Y; Bejerano-Sagie M; Kogan NM; Karpuj MV; Kaganovich D; Cohen E
J Cell Sci; 2011 Jun; 124(Pt 11):1891-902. PubMed ID: 21558416
[TBL] [Abstract][Full Text] [Related]
17. Proteasome degradation of protein C and plasmin inhibitor mutants.
Nishio M; Koyama T; Nakahara M; Egawa N; Hirosawa S
Thromb Haemost; 2008 Sep; 100(3):405-12. PubMed ID: 18766255
[TBL] [Abstract][Full Text] [Related]
18. The aggresome pathway as a target for therapy in hematologic malignancies.
Simms-Waldrip T; Rodriguez-Gonzalez A; Lin T; Ikeda AK; Fu C; Sakamoto KM
Mol Genet Metab; 2008 Jul; 94(3):283-6. PubMed ID: 18472289
[TBL] [Abstract][Full Text] [Related]
19. Aggresome formation and neurodegenerative diseases: therapeutic implications.
Olzmann JA; Li L; Chin LS
Curr Med Chem; 2008; 15(1):47-60. PubMed ID: 18220762
[TBL] [Abstract][Full Text] [Related]
20. Protein degradation and protection against misfolded or damaged proteins.
Goldberg AL
Nature; 2003 Dec; 426(6968):895-9. PubMed ID: 14685250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
